Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis [5]

Clinical and Experimental Rheumatology

Volumn 24, Issue 2 SUPPL. 41, 2006, Pages

  Tektonidou, Maria G ^a   Skopouli, F N ^a  

^a Athens Euroclinic   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ADULT; ANEMIA; ARTHRALGIA; CASE REPORT; DIARRHEA; FEMALE; GLOMERULONEPHRITIS; HUMAN; LEG EDEMA; LETTER; LEUKOCYTOCLASTIC VASCULITIS; LUNG NODULE; MOUTH ULCER; PRIORITY JOURNAL; PURPURA; RASH; REMISSION; SIDE EFFECT; SKIN ULCER; SMALL VESSEL VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; REMISSION INDUCTION; TIME FACTORS; WEGENER GRANULOMATOSIS;

EID: 33745726576     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. SPECKS U, FERVENZA FC, MC DONALD TJ, HOGAN MC: Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001; 44: 2836-40.
2. STONE JH, HOFFMAN GS, MERKEL PA et al.: A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001; 44: 912-20.
3. CHAMBERS SA, ISENBERG D: Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases. Lupus 2005; 14: 210-4.
4. ARMSTRONG DJ, WRIGHT SA, FINCH MB, TAGAART AJ, BELL AL: Active systemic lupus erythematosus successfully treated with rituximab and oral steroids. Clin Exp Rheumatol 2004; 22: 787-8.
5. KEYSTONE EC: Safety issues related to emerging therapies for rheumatoid arthritis. Clin Exp Rheumatol 2004; 22 (Suppl. 35): S148-50.
6. ERIKSSON P: Short-term outcome and safety in 5 patients with ANCA-positive vasculitis treated with rituximab (abstract). Kidney Blood Press Res 2003; 26: 294.
7. JAYNE DR, BURNS S, SMITH K: B-cell depletion with rituximab for refractory vasculitis (abstract). Kidney Blood Press Res 2003; 26: 294.
8. KEOGH KA, WYLAM ME, STONE JH, SPECKS U: Induction of remission by B Lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005; 52: 262-8.